Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Recurrence 1 Pathologic Complete Response 1 Lymphoma, Follicular 1 Lymphatic Metastasis 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Disease 1 Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients 1 Brain Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Temozolomide 12 Magnetic Resonance Spectroscopy 9 Radiotherapy 6 Surveys and Questionnaires 5 Blood Specimen Collection 4 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Radiation 3 Perfusion Magnetic Resonance Imaging 2 Magnetic Resonance Imaging 2 Lomustine 2 Immunotherapy 2 Drug Therapy 2 Chemoradiotherapy 2 Amplified Fragment Length Polymorphism Analysis 2 regorafenib 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 gadodiamide 1 apatinib 1 Ultrasonography 1 Trail Making Test 1 Therapies, Investigational 1 Tablets 1 Standard of Care 1 Specimen Handling 1 Sampling Studies 1 Re-Irradiation 1 Quality of Life 1 Psychometrics 1 Proton Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Glioblastoma × Diffusion Magnetic Resonance Imaging × Clear all

NCT07532031 2026-04-15

APT-HGG

IRCCS Ospedale San Raffaele

Not yet recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡